A new report released found that the majority pharmaceutical drugs used to combat malaria are bogus or of poor quality.
The Fogarty International Center at the US national Institutes of Health (NH) funded a study that found a shocking 20 to 42% of the malaria vaccines used in Southeast Asia and sub-Saharan Africa are of substandard quality or absolutely fake.
By researching studies and publications, the report explains that, according to the Southeast Asian countries, 36% of the 1,437 samples of malaria vaccines were counterfeit.
Another 30% of samples could not test positive for the pharmaceutical compounds that would be in a malaria vaccine.
Those drugs given to Africa were discovered to be bogus as well, with 20% of more than 2,500 samples in 6 drug classes showing that they are not real. Thirty-five percent were under drug corporation standards.
“These findings are a wake-up call demanding a series of interventions to better define and eliminate both criminal production and poor manufacturing of anti-malarial drugs,” said Dr. Joel Breman, a senior scientist emeritus at NIH.
Non-profit organizations like the Medicines for Malaria Venture, Roll Back Malaria, Netting Nations, Malaria No More, Project Mosquito Net, Nothing But Nets, and the Red Cross are administering vaccines to combat malaria that are having no medical effect on the disease.
This indicates that the pharmaceutical corporations and the non-profits are intentionally misleading these nations into taking these drugs.
“The economic incentives for criminals of drug falsification surpass the risks involved in their production and sale,” stated the study, which was published in the Lancet Infectious Diseases journal.
GTC Bio-therapeutics, a Massachusetts-based pharmaceutical company, created this malaria vaccine more than a decade ago.
The Bill and Melinda Gates Foundation (BMGF) has been one of the most prominent advocates for the malaria vaccine . It is little known that several members of the Bill & Melinda Gates Foundation management committee, leadership teams, affiliates, and major funders are currently or were previously members of the boards or executive branches of several major drug makers , including Merck and Novartis.
BMGF holdings are invested in Berkshire Hathaway, which the researchers write has significant ownership in GlaxoSmithKline, Sanofi-Aventis Johnson & Johnson.
BMGF held stock in Merck at a time when it developed partnerships with the African Comprehensive AIDS and Malaria Partnership and the Merck Company Foundation to test Merck products . . . on unsuspecting Africans.
BMGF claims that:
Between 2000 and 2006, several countries in Africa saw a 50 percent decrease in malaria by using a combined set of effective interventions, including insecticide-treated bed nets and indoor spraying of homes with insecticides to control mosquitoes, and drug treatments to prevent and cure malaria.
The goal of the BMGF and the Global Alliance for Vaccines and Immunizations (GAVI) to vaccinate every human being on the planet.
The World Health Organization (WHO) reports that:
- In 2010 655,000 killed by malaria
- 2,000 children killed in Africa
- 3.3 billion killed worldwide
WHO purports that, 200,000 deaths could be avoided by administering the malaria vaccine.
When the majority of the vaccines administered by organizations like WHO, GAVI and BMGF are fake how is the disease being prevented?
WHO, one of GAVI’s partners , has teamed up with the World Bank and UN Population Fund in the 1970s under the Task Force on Vaccines for Fertility Regulation. The Task Force, “…acts as a global coordinating body for anti-fertility vaccine R&D.” GAVI is heavily funded by the BMGF for the global vaccination projects.
The scientific community is working on developing strange alternatives to administering the malaria vaccine. Researchers at the Texas A&M University (A&M) have revealed their latest genetically modified project; GM goats that unnaturally produce the malaria vaccine in their milk.
After altering the genome of goats to produce the malaria parasite, the scientists were successful in producing goat’s milk with genetic materials that are found in the malaria vaccine.
“Our ultimate, ultimate idea is to continue the research to the point to where you actually have a herd of goats that are producing vaccines, pharmaceuticals and nutraceuticals . . . in their milk . . . just go out and drink the milk and get vaccinated,” said Mark Westhusin, scientist who participated in the experiment.
It is expected that this study’s findings will create a stir within the international community.
How can governments trust pharmaceutical makers who produce faulty drugs or purvey fakes as authentic?
No doubt the fraudulent medicines cost the same as real ones.
Susanne Posel is the Chief Editor of Occupy Corporatism.